ICP-MS determination of serum aluminum in monkeys subcutaneously administered an alhydrogel-formulated drug candidate

Bioanalysis. 2017 Dec;9(23):1873-1881. doi: 10.4155/bio-2017-0177. Epub 2017 Nov 24.

Abstract

Aim: To develop and validate an inductively coupled plasma-mass spectrometry method for quantitative bioanalysis of aluminum (Al) in monkey serum in support of a GLP TOX study with alhydrogel-formulated drug candidate.

Methods & results: The method was linear over a dynamic range of 10-1000 ng/ml using a 50-μl sample volume. The intra-/inter-run precision (%CV) of the quality control sample results were ≤7.9% (CV) and the accuracy (%bias) within ±11.0% across all quality control concentrations evaluated. Other validation parameters, including stability under various conditions, extraction recovery and matrix effect, all met the acceptance criteria.

Conclusion: The validated method was successfully implemented for the quantitative analysis of Al in monkey serum to assess the systemic exposure to Al.

Keywords: ICP–MS; alhydrogel; aluminium; determination.

MeSH terms

  • Aluminum / blood*
  • Aluminum / standards
  • Aluminum Hydroxide / chemistry*
  • Animals
  • Drug Compounding
  • Haplorhini
  • Limit of Detection
  • Mass Spectrometry / methods*
  • Mass Spectrometry / standards
  • Quality Control
  • Reproducibility of Results

Substances

  • Aluminum Hydroxide
  • Aluminum